2.7.6-1 - Pmda

55

Transcript of 2.7.6-1 - Pmda

Page 1: 2.7.6-1 - Pmda
Page 2: 2.7.6-1 - Pmda
Page 3: 2.7.6-1 - Pmda
Page 4: 2.7.6-1 - Pmda
Page 5: 2.7.6-1 - Pmda
Page 6: 2.7.6-1 - Pmda
Page 7: 2.7.6-1 - Pmda
Page 8: 2.7.6-1 - Pmda
Page 9: 2.7.6-1 - Pmda
Page 10: 2.7.6-1 - Pmda
Page 11: 2.7.6-1 - Pmda
Page 12: 2.7.6-1 - Pmda
Page 13: 2.7.6-1 - Pmda
Page 14: 2.7.6-1 - Pmda
Page 15: 2.7.6-1 - Pmda
Page 16: 2.7.6-1 - Pmda
Page 17: 2.7.6-1 - Pmda
Page 18: 2.7.6-1 - Pmda
Page 19: 2.7.6-1 - Pmda
Page 20: 2.7.6-1 - Pmda
Page 21: 2.7.6-1 - Pmda
Page 22: 2.7.6-1 - Pmda
Page 23: 2.7.6-1 - Pmda
Page 24: 2.7.6-1 - Pmda
Page 25: 2.7.6-1 - Pmda
Page 26: 2.7.6-1 - Pmda
Page 27: 2.7.6-1 - Pmda
Page 28: 2.7.6-1 - Pmda
Page 29: 2.7.6-1 - Pmda
Page 30: 2.7.6-1 - Pmda
Page 31: 2.7.6-1 - Pmda
Page 32: 2.7.6-1 - Pmda
Page 33: 2.7.6-1 - Pmda
Page 34: 2.7.6-1 - Pmda
Page 35: 2.7.6-1 - Pmda
Page 36: 2.7.6-1 - Pmda
Page 37: 2.7.6-1 - Pmda
Page 38: 2.7.6-1 - Pmda
Page 39: 2.7.6-1 - Pmda
Page 40: 2.7.6-1 - Pmda
Page 41: 2.7.6-1 - Pmda
Page 42: 2.7.6-1 - Pmda
Page 43: 2.7.6-1 - Pmda
Page 44: 2.7.6-1 - Pmda
Page 45: 2.7.6-1 - Pmda
Page 46: 2.7.6-1 - Pmda
Page 47: 2.7.6-1 - Pmda
Page 48: 2.7.6-1 - Pmda
Page 49: 2.7.6-1 - Pmda
Page 50: 2.7.6-1 - Pmda
Page 51: 2.7.6-1 - Pmda
Page 52: 2.7.6-1 - Pmda
Page 53: 2.7.6-1 - Pmda
Page 54: 2.7.6-1 - Pmda
Page 55: 2.7.6-1 - Pmda

PMDA Perspective on Regulatory Commitments1 Yoshihiro Matsuda, Ph.D. Office of Standards and Guidelines Development Pharmaceuticals and Medical Devices Agency (PMDA) PMDA Perspective

PMDA Perspective on Regulatory Commitments1 Yoshihiro Matsuda, Ph.D. Office of Standards and Guidelines Development Pharmaceuticals and Medical Devices Agency (PMDA) PMDA Perspective

Regulatory Update from MHLW/PMDA - 独立行政法人 ... · Regulatory Update from MHLW/PMDA ... PMDA Asia Training Center 2. 1. Organizational Updates 3. ... • GLP/GCP/GPSP compliance

Regulatory Update from MHLW/PMDA - 独立行政法人 ... · Regulatory Update from MHLW/PMDA ... PMDA Asia Training Center 2. 1. Organizational Updates 3. ... • GLP/GCP/GPSP compliance

PMDA Perspective

PMDA Perspective

DNA - 医薬品医療機器総合機構 · DNA DNA PMDA . PMDA PMDA . Created Date: 3/31/2014 2:01:02 PM

DNA - 医薬品医療機器総合機構 · DNA DNA PMDA . PMDA PMDA . Created Date: 3/31/2014 2:01:02 PM

Q12 Annexes - Pmda

Q12 Annexes - Pmda

MAKALAH 3 PMDA

MAKALAH 3 PMDA

Voluntary Recall - Pmda

Voluntary Recall - Pmda

Page 301 of 2131 - Pmda

Page 301 of 2131 - Pmda

PMDA Perspective: Recent Trends in the Regulation of ... · Regulation of Biopharmaceuticals. Pharmaceuticals and Medical Devices Agency 2 PMDA Asia Training Center (PMDA-ATC) ...

PMDA Perspective: Recent Trends in the Regulation of ... · Regulation of Biopharmaceuticals. Pharmaceuticals and Medical Devices Agency 2 PMDA Asia Training Center (PMDA-ATC) ...

AMED Board AMED PD, PS, PO AMED AMED PMDA iPS NationalClinical Database PMDA AMED AMED

AMED Board AMED PD, PS, PO AMED AMED PMDA iPS NationalClinical Database PMDA AMED AMED

Novell iManager 2.7.6 Installation Guide - NetIQ

Novell iManager 2.7.6 Installation Guide - NetIQ

Oxytocin - Pmda

Oxytocin - Pmda

Ipilimumab 2.7.6 個々の試験のまとめ Page 1...Ipilimumab 2.7.6 個々の試験のまとめ Page 1 CTD 第2部 2.7 臨床概要 2.7.6 個々の試験のまとめ ブリストル・マイヤーズ株式会社

Ipilimumab 2.7.6 個々の試験のまとめ Page 1...Ipilimumab 2.7.6 個々の試験のまとめ Page 1 CTD 第2部 2.7 臨床概要 2.7.6 個々の試験のまとめ ブリストル・マイヤーズ株式会社

pmda madiun

pmda madiun

KUISIONER PMDA

KUISIONER PMDA

CEFTAZIDIME - Pmda

CEFTAZIDIME - Pmda

NIFEDIPINE - Pmda

NIFEDIPINE - Pmda

2.7.6 Conjugate Gradient Method for a Sparse System

2.7.6 Conjugate Gradient Method for a Sparse System

Latest Activities of PDG - Pmda

Latest Activities of PDG - Pmda

Report on Deliberation Results - Pmda

Report on Deliberation Results - Pmda